Tag:
Sygnis Pharma
Latest Headlines
Latest Headlines
Sygnis Pharma's shares plunge as key stroke drug fails PhII
Germany's Sygnis Pharma ( $LIOK ) says its lead drug failed a mid-stage stroke trial, flunking both the primary and secondary endpoints and triggering a meltdown in its share price. AX200 is designed
